Last updated on February 2018

Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers


Brief description of study

Sample Collection Study

Detailed Study Description

This is a limited prospective collection of whole blood samples from pregnant women with a diagnosis of preterm preeclampsia and/or fetal growth restriction in addition to samples from a control group to aid in the development of a Next Generation Sequencing (NGS)-based assay to detect molecular markers associated with preterm preeclampsia.

Clinical Study Identifier: NCT02808494

Contact Investigators or Research Sites near you

Start Over

Daniel Skupski

New York-Presbyterian/Queens
Flushing, NY United States
2.48miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.